AFZAL HUSSAIN

Dr. AFZAL HUSSAIN


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2022 in Nanomedicine
Verified
Journal Article
Closed access
GKGourvi Kumari
Gourvi Kumari
KAKumar Abhishek
Kumar Abhishek
SSSneha Singh
Sneha Singh
AHAFZAL HUSSAIN
AFZAL HUSSAIN
MAMohammad Altamimi
Mohammad Altamimi
ADAbhimanyu Dev
Abhimanyu Dev
Recent advancements in biomedical tissue engineering are gaining wide interest. Implementing biology of living cells and organisms using technological solutions such as incorporating 4D printing an... Graphical abstract

22 October 2015 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
PDF file
AHAFZAL HUSSAIN
AFZAL HUSSAIN
CVChandan Kumar Verma
Chandan Kumar Verma
UCUsha Chouhan
Usha Chouhan
Cell cycle consists of different types of phases, transition from G1, S, G2, M. Inhibition of associated CDKs like CDK9/Cyclin T1 complex, which are indirectly involved in the Cell cycle progression in the form of transcription elongation, reduces diverse diseases such as Cardiac Hypertrophy, Alzheimer’s, Cancer, AIDS and Inflammation. Glide tool of the Schrodinger software has been used for performing Structure Based Virtual Screening and Docking against Drug Bank and MDPI database. The best hits were identified which go and bind in the active site of the target where ATP binds for the activity. The ADMET, MM-GBSA and DFT analysis is also done for the same. Compound 4-{4-[4-(3-aminopropoxy)phenyl]-1H-pyrazol-5-yl}-6-chlorobenzene-1,3-diol (DB08045) was found to be more potent, novel and selective as an inhibitor. Hopefully compound (DB08045) could be used as an anti-cancer agent for the treatment of life-threatening diseases.

1 June 2021 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
AHAFZAL HUSSAIN
AFZAL HUSSAIN
CVChandan Kumar Verma
Chandan Kumar Verma
Candida albicans is a yeast that is an opportunistic fungal pathogen and also identified as ubiquitous polymorphic species that is mainly linked with major fungal infections in humans, particularly in the immunocompromised patients including transplant recipients, chemotherapy patients, HIV-infected patients as well as in low-birth-weight infants. Systemic Candida infections have a high mortality rate of around 29 to 76%. For reducing its infection, limited drugs are existing such as caspofungin, fluconazole, terbinafine, and amphotericin B, etc. which contain unlikable side effects and also toxic. This review intends to utilize advanced bioinformatics technologies such as Molecular docking, Scaffold hopping, Virtual screening, Pharmacophore modeling, Molecular dynamics (MD) simulation for the development of potentially new drug candidates with a drug-repurpose approach against Candida albicans within a limited time frame and also cost reductive.

3 February 2022 in Nanomedicine
Verified
Journal Article
Closed access
GKGourvi Kumari
Gourvi Kumari
KAKumar Abhishek
Kumar Abhishek
SSSneha Singh
Sneha Singh
AHAFZAL HUSSAIN
AFZAL HUSSAIN
MAMohammad Altamimi
Mohammad Altamimi
ADAbhimanyu Dev
Abhimanyu Dev
The transition from 3D to 4D printing has revolutionized various domains of healthcare, pharmaceuticals, design and architecture, and coating processes. The evolution from 3D printing to 4D printin... Graphical abstract

1 July 2021 in Coronaviruses
Verified
Journal Article
Open access
PDF file
AHAFZAL HUSSAIN
AFZAL HUSSAIN
AHAshfaq Hussain
Ashfaq Hussain
CVChandan Kumar Verma
Chandan Kumar Verma
Nigella sativa (Family Ranunculaceae) is a common medicinal plant all across the world. It is quite popular in different traditional medicinal systems such as Unani, Ayurveda, Tibb, and Siddha. Oil and Seeds have a long tradition of folk medicine utilized in different medicinal systems and food. The seeds of N. Sativa have indeed been widely applied in the treatment of many diseases, ailments, and also as an immune booster. Our research goal was to primarily concentrate on the therapeutic efficacy of Nigella sativa in combating the COVID-19 pandemic.

11 April 2022 in New Microbes and New Infections
Verified
Journal Article
Open access
AHAFZAL HUSSAIN
AFZAL HUSSAIN